Inovio Covid-19 Vaccine Trial Placed on Hold After FDA Questions

news image

A planned later-stage trial for a Covid-19 vaccine from Inovio Pharmaceuticals Inc. is on hold, after U.S. health regulators raised questions, the company said.

The delay means the Phase 2/3 trial for Inovio’s experimental vaccine won’t begin until October at the earliest.

Inovio shares fell as much as 33% on Monday after the trial hold was…


Leave a Reply

Your email address will not be published. Required fields are marked *

Pin It on Pinterest